SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (885)10/8/2003 2:06:02 PM
From: Biomaven  Respond to of 3557
 
Doesn't that argue for another PII ?

Well this is going to be up to Novartis. They might decide that a 2-dose Phase III is the way to go - more risky and hence expensive, but it gets an answer sooner.

I'm not sure how high they went in safety studies, so possibly you would need another safety study before proceeding with a high-dose Phase III.

Peter